24 lh May, 2017 To. Corporate Relationship Department, 7, Lyons Range, SSE Limited, Kolkata P. J. Tower, Mumbai

Size: px

Start display at page:

Download "24 lh May, 2017 To. Corporate Relationship Department, 7, Lyons Range, SSE Limited, Kolkata P. J. Tower, Mumbai"

Irene Clark
5 years ago
Views:

1 MAVENS ON NO.: W81981PLC lh May, 2017 To To The Secretary, Dy, General Manager, The Calcutta Stock Exchange Limited, Corporate Relationship Department, 7, Lyons Range, SSE Limited, Kolkata P. J. Tower, Mumbai SUB: Submission of Audited Financial Results for the 04 tb Quarter and year ended 31$t March, 2017 pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of Board of Directors of the Company held at its Registered Office on Wednesday, 24th May, 2017 (which commenced at 3.30 P.M. and concluded at 5.25 P.M.) wherein they have adopted / approved: 1) The Audited Standalone Financial Results of the Company for the 4 t1 quarter and Year ended alongwith the Statement of Assets and Liabilities. 2) Auditor's Report on the Annual Standalone Audited Standalone Financial Results. 3) Declaration by Whole-Time Director pursuant to Regulation 33(3) (d) of the SEBI floor) Regulation, The said results will be duly published in the newspapers within due course of time. The above information is also available on Company's website and on the Stock exchange website: and www,cse-india,coffi. Request you to kindly take the above on record. Thanking you, Yours faithfully, For Mavens.- o~ 0'r--"'(\~ ~~'\~. (/)( r ""', r" Bharat Kumar Sah Z(KOLKATA)- Whole Time Director WI... I ~.., \,.i'... DIN: " '... A ")f ~-*O? Enci.: As Above Registered Office: Room No. 407, 4'hFloor, No.4 Clive Row, Kolkata Tel: investors@mavensbiotech.com - Website:

2 MAVENS ( IN NO.: ll7297w81981plc MAYENS BIOTECH LIMITED ON:L17297WB1981PLC Statement ofslandalone Audited Financial Results for the4th Quarter and Year Ended 31st March, 2017 PARTl [Rs.in Lakhs) Sr.No. Particulars 3months Preceding 3 Corresponding Year to date Year to date ended months ended 3months ended /\,aures for figures for [31/03}2017) ( ) ~1/03f2016) In current period previous year the previous ended ended year (31/ ) (31103/2016) Audited Unaudited Audited Audited Audited [ Revenue from 0peratio us II Other [nco me ill Total RevenueptU) IV Expenses (ajcost ormaterials consumed (bj Purchases ofstock-in-trade - (c)cbanges in inventories of finishedgoods,work-in.progress and 6.16 R stock-in-llilde (d) Employeebenefits expense (e)finance Cost - (ndepreciation andamortisation expense (g) Other expenses Total expenses 1B, , ,63 V Profit before exceptional and extraordinary items and tax[lu , IV) VI Exceptional items VII Pro fit before extraordinary items and tax (V tl: VI) vm Extraordinary items - IX Profitbefore tax (VIl+/. VI U) 0, , X Tax expense (l)currenttax (2) DeferredTax (0.65) XI Profit (Loss) for the period from continuing operations (IK-X) B6 0.8S 2, XlI Profi t/poss) fro mdiscontinuingoperations. Xlll Tax expense of discontinuing operations XIV Profit/Ooss)fro mdiscontinuing operations [after tax)(xij.xill) XV Profit (Loss) for the period (X1t1 X1 V) O.8S XVI Earnings Per Share (Equity Share of Rs.1/ eachllnot annua!isedl. ~ (a) Basic r, 'OT E o> \ (b) Diluted fl 0 r,-..." /y.r' ~~o;, -/, " ' V). \ KOLKATA )i, \ '... "7 " ) 'y.. "_... O~ I1f * Registered Office : Room No. 407, 4 th Floor, NO.4 Clive Row, Kolkata Tel: investors@mavensbiotech.com - Website : ch.com

3 MAVENS BIOTECH LIMlTED Statement of Assets and Liabilities as at 31st March, 2017 MAVENS ON NO.: ll7297wb1981plc (Rs. in Lakhs) Standalone Statement ofassets and Liabilities Ason As on Particulars Audited Audited A EQUITY AND LIABILITIES 1 Shareholders' funds (a) Share capital , (b) Reserves and surplus Sub-total Shareholders' funds 1, , Current liabilities (a) Other Current Liabilities (b) Short-term Provisions Sub-total- Current Liabilities TOTAL EQUITY ANDLIABILITIES 1, , BASSETS 1 Non-current assets (a) Fixed assets (i) Tangible Assets (ii) Capital Work in Progress (b) Non-Current Investments (c) Deferred Tax Assets (Net) (d) Long-term loans and advances I (elather Non Current Assets Sub-total- Non-current assets 1, , Current assets (a) Trade Receivables (b1cash and cash equivalents Sub-total - Current assets Notes: TOTAL ASSETS 1, , The above Financial results have been reviewed by the Audit committee held on 23 rd May, 2017 and adopted by the Board of Directors at their meeting held on 24 th May, Registered Office: Roo m No. 407, 4 th Floor, NO. 4 Clive Row, Kolkata Tel: mail: investors@mavensbiotech.com Website:

4 AVENS (I N NO.: Ll7297WB1981PLC The Result are based on the Standalone Financial Statement prepared by the Company's management in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section 133 of the Companies Act, 2013 read with relevant rules issued there under. The Standalone Financial Results are made available to the Stock Exchange where the Company's securities are listed and are posted on the Company's website 3. There is only one reportable segment i.e, Income from Trading in Commodities and its allied products" by Accounting Standard 17 "Segment Reporting" prescribed by the Companies (Accounting Standards) Rules, Provision for taxation is made on the taxable income for the full year in accordance with the provision of Income Tax Act, S. The figures of last Quarter for the Standalone account are the balancing figures between the audited figures in respect of the full Financial Year ended 31 st March, 2017 and the unaudited published year to date figures upto 31 st December, 2016 which are subject to Limited Review. 6. Figures of the previous period have been regrouped wherever necessary. By order of the Board ~ For Mavens / :-O T «.: 0 'r -----~,Iy r Place : Kolkata, Date : _.. ( VJ ' "o,\~-±-. ("" k\j_ r "[. 1 KOLKATA)- ' BharatKumarSah W" ) ~ Whole Time Director " " ~ '..I 'y... DIN: '".. ""...:110.. '" "'* Registered Office: Ro~m. No. 407, 4'hFloor, NO.4 Clive Row, Kolkata Tel: ; Investors@mavensbiotech.com - Website:

5 MOHINDRA ARORA B CO. BRANCH OFFICE: CHARTERED ACCOUNTANT Darya Nagar House, 3rd Floor, Room No. 31, 67-69, Maharishi Karve Marg, Marine Lines, Mumbai Tel.: mohindraarora2010@gmail.com Annexure VIl Auditor's Report on Quarterly Financial Results and Year to Date Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To, Board of Directors of Mavens We have audited the quarterly financial results of Mavens for the quarter ended 31Sl March, and the year to date results for the period 01$1 April, 2016 to March, 2017 attached herewith, being submitted by the company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, These quarterly financial results as wen as the year to date financial results have been prepared on the basis ofthe related financial statements, which are the responsibility of the company's management and approved by the Board of Directors. Our responsibility is to express an opinion on these financial results based on our audit of such financial statements, which have been prepared in accordance with the recognition and measurement principles laid down in Accounting Standard prescribed, under Section 133 ofthe Companies Act, 2013 read with relevant rules issued there under, as applicable and other accounting principles generally accepted in India. We conducted our audit in accordance with the auditing standards generally accepted in India. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial results are free of material misstatement(s). An audit includes examining, on a test basis, evidence supporting the amounts disclosed as financial results. An audit also includes assessing the accounting principles used and significant estimates made by management. We believe that our audit provides a reasonable basis for our opinion. In OUf opinion and to the best of our information and according to the explanations given to us these quarterly financial results as well as the year to date results : (i) are presented in accordance with the requirements of Regulation 33 ofthe SEBI (Listing Obligations and Disclosure Req uirements) Regul ations, 2015 in this regard; and (ii) give a true and fair view of the net profit and other financial information for the quarter ended March, 2017 as well as the year to date results for the period from I$I April, 2016 to March, For Mohindra Arora & Co. Chartered Accountants ~::::r Katla Partner M. No Place: Mumbai Date :23/05/2017 HEAD OFFICE: Kothl No.26A, C Block, 3rdFloor, Guru Virja Nand Marg, Vlkashpuri, New Delhi Tel. : f Fax:

6 (IN NO,: Ll7297W81981PLC th May, 2017 DECLARATION I, Bharat Kumar Sah (DIN: ) Whole -Tirne Director of Mavens, hereby declared and confirmed that, the Statutory Auditors of the Company, Mis. Mohindra Arora & Co., Chartered Accountants (FRN: 00655IN) have issued an Audit Report with unmodified opinion on AnnualAudited Standalone Financial Results for the quarter and year ended 31 st March,2017. This declaration is issued in compliance of Regulation 33(3)(d) of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015 as amended by the Securities Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2016 vide notification No. SEBl/LAD-NRO/GN/ IDOl and Circular No. CIR/CFD/CMDj56j2016. Thankingyou, Yoursfaithfully, For Mavens, ~ " T f, O~C.L. f3 "" ~~ I Bharat Kumar Sah Whole Time Director \)\ \. ) _ DIN: r~ \....../.)'y '\, ~.- - ().~ ~,r *1, Encl.: Asabove ~ -' 0/ "", V) (,t'" Z ( KOLKAT A )i ' Registered Office: Ro~~ No. 407, 4'" Floor, No.4 Clive Row, Kolkata Tel: IOvestors@mavensbiotech.com - Website:

The Dept. of Corporate Services, The Calcutta Stock Exchange Ltd.,

The Dept. of Corporate Services, The Calcutta Stock Exchange Ltd., QUEST FINANCIAL SERVICES LTD. Centre Point, 21, Hemanta Basu Sarani, Room No.- 230, 2 nd Floor, Kolkata-700 001 Phone No. +919831526324, E-Mail ID - investorsquestfinancial@yahoo.co.in, Website-www.questfinancial.in,